WVE insider transactions
Wave Life Sciences Ltd. (WVE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for WVE
- SEC Form 3 filed by new insider Wright Christopher I3 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- SEC Form 3 filed by new insider Ingelsson Erik3 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- SEC Form 4 filed by Ra Capital Management, L.P.4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- SEC Form 4 filed by Takanashi Ken4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Officer Francis Chris exercised 33,194 units of Ordinary Shares at a strike of $4.28 and sold $499,593 worth of Ordinary Shares (33,194 units at $15.05) (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Chief Financial Officer Moran Kyle was granted 45,625 units of Ordinary Shares and sold $48,259 worth of Ordinary Shares (3,588 units at $13.45), increasing direct ownership by 46% to 134,385 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- President and CEO Bolno Paul was granted 165,000 units of Ordinary Shares and sold $140,956 worth of Ordinary Shares (10,480 units at $13.45), increasing direct ownership by 128% to 275,520 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Officer Francis Chris was granted 38,750 units of Ordinary Shares and sold $25,326 worth of Ordinary Shares (1,883 units at $13.45), increasing direct ownership by 147% to 61,867 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Officer Vargeese Chandra was granted 45,625 units of Ordinary Shares and sold $43,417 worth of Ordinary Shares (3,228 units at $13.45), increasing direct ownership by 12% to 408,246 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Officer Francis Chris exercised 9,375 units of Ordinary Shares at a strike of $3.14 and sold $150,260 worth of Ordinary Shares (9,375 units at $16.03) (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Large owner Gsk Plc bought $27,930,000 worth of Ordinary Shares (1,470,000 units at $19.00) (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Officer Francis Chris exercised 441,031 units of Ordinary Shares at a strike of $4.78 and sold $6,427,085 worth of Ordinary Shares (441,031 units at $14.57) (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Tan Aik Na sold $1,823,158 worth of Ordinary Shares (134,218 units at $13.58) and exercised 119,230 units of Ordinary Shares at a strike of $4.85, decreasing direct ownership by 37% to 25,400 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Henry Christian O sold $1,369,324 worth of Ordinary Shares (93,445 units at $14.65) and exercised 87,000 units of Ordinary Shares at a strike of $5.07, decreasing direct ownership by 34% to 12,700 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- SEC Form 4 filed by insider4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Chief Financial Officer Moran Kyle exercised 296,000 units of Ordinary Shares at a strike of $5.20 and sold $4,103,979 worth of Ordinary Shares (260,036 units at $15.78), increasing direct ownership by 1% to 90,365 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Verdine Gregory L. sold $269,461 worth of Ordinary Shares (20,000 units at $13.47), decreasing direct ownership by 7% to 275,217 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Rawcliffe Adrian exercised 42,000 units of Ordinary Shares at a strike of $5.97 and sold $630,000 worth of Ordinary Shares (42,000 units at $15.00) (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Corrigan Mark sold $217,297 worth of Ordinary Shares (16,115 units at $13.48), decreasing direct ownership by 36% to 28,815 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Rawcliffe Adrian sold $109,421 worth of Ordinary Shares (16,115 units at $6.79), decreasing direct ownership by 56% to 12,700 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Ra Capital Management, L.P. bought $6,688 worth of Ordinary Shares (1,000 units at $6.69) (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- President and CEO Bolno Paul sold $2,194,810 worth of Ordinary Shares (217,351 units at $10.10), decreasing direct ownership by 64% to 121,000 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Verdine Gregory L. sold $100,000 worth of Ordinary Shares (10,000 units at $10.00), decreasing direct ownership by 3% to 285,217 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Tan Aik Na exercised 21,000 units of Ordinary Shares at a strike of $9.13 and sold $194,250 worth of Ordinary Shares (21,000 units at $9.25) (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Ra Capital Management, L.P. was granted 12,700 units of Ordinary Shares (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Corrigan Mark was granted 12,700 units of Ordinary Shares, increasing direct ownership by 39% to 44,930 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Verdine Gregory L. was granted 12,700 units of Ordinary Shares, increasing direct ownership by 4% to 295,217 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Wagner Heidi L was granted 12,700 units of Ordinary Shares, increasing direct ownership by 39% to 44,930 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Takanashi Ken was granted 12,700 units of Ordinary Shares, increasing direct ownership by 0.22% to 5,729,003 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Tan Aik Na was granted 25,400 units of Ordinary Shares, increasing direct ownership by 169% to 40,388 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Rawcliffe Adrian was granted 12,700 units of Ordinary Shares, increasing direct ownership by 79% to 28,815 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Henry Christian O was granted 12,700 units of Ordinary Shares and sold $85,193 worth of Ordinary Shares (9,670 units at $8.81), increasing direct ownership by 11% to 29,645 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Takanashi Ken sold $42,630 worth of Ordinary Shares (4,872 units at $8.75), decreasing direct ownership by 0.09% to 5,716,303 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Tan Aik Na sold $9,861 worth of Ordinary Shares (1,127 units at $8.75), decreasing direct ownership by 7% to 14,988 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Verdine Gregory L. sold $208,500 worth of Ordinary Shares (30,000 units at $6.95), decreasing direct ownership by 10% to 282,517 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Henry Christian O sold $102,574 worth of Ordinary Shares (10,500 units at $9.77) and exercised 10,500 units of Ordinary Shares at a strike of $9.13 (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- President and CEO Bolno Paul exercised 169,025 units of Ordinary Shares at a strike of $2.48 and sold $1,617,569 worth of Ordinary Shares (169,025 units at $9.57) (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Verdine Gregory L. exercised 266,402 units of Ordinary Shares at a strike of $2.48, increasing direct ownership by 577% to 312,517 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Officer Vargeese Chandra exercised 91,754 units of Ordinary Shares at a strike of $2.48, increasing direct ownership by 34% to 362,687 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Chief Financial Officer Moran Kyle was granted 42,000 units of Ordinary Shares, increasing direct ownership by 89% to 89,218 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Officer Francis Chris was granted 25,000 units of Ordinary Shares (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- President and CEO Bolno Paul was granted 121,000 units of Ordinary Shares, increasing direct ownership by 56% to 338,351 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Officer Vargeese Chandra was granted 37,000 units of Ordinary Shares, increasing direct ownership by 16% to 270,933 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Officer Vargeese Chandra exercised 46,000 units of Ordinary Shares at a strike of $2.48, increasing direct ownership by 24% to 233,933 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- President and CEO Bolno Paul sold $750,000 worth of Ordinary Shares (50,000 units at $15.00) and exercised 50,000 units of Ordinary Shares at a strike of $2.48 (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- President and CEO Bolno Paul sold $733,671 worth of Ordinary Shares (51,234 units at $14.32), decreasing direct ownership by 19% to 217,351 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Officer Francis Chris exercised 36,000 units of Ordinary Shares at a strike of $8.17 and sold $576,000 worth of Ordinary Shares (36,000 units at $16.00) (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- President and CEO Bolno Paul sold $1,357,110 worth of Ordinary Shares (90,474 units at $15.00), decreasing direct ownership by 25% to 268,585 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Officer Francis Chris sold $2,855,051 worth of Ordinary Shares (208,836 units at $13.67) and exercised 129,122 units of Ordinary Shares at a strike of $2.88, closing all direct ownership in the company (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Chief Financial Officer Moran Kyle exercised 25,000 units of Ordinary Shares at a strike of $2.48, increasing direct ownership by 126% to 44,777 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Large owner Gsk Plc bought $22,335,440 worth of Ordinary Shares (2,791,930 units at $8.00) (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Chief Financial Officer Moran Kyle sold $154,314 worth of Ordinary Shares (17,146 units at $9.00), decreasing direct ownership by 46% to 19,777 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- President and CEO Bolno Paul sold $279,555 worth of Ordinary Shares (48,366 units at $5.78), decreasing direct ownership by 12% to 359,059 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Ra Capital Management, L.P. was granted 16,115 units of Ordinary Shares (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Rawcliffe Adrian was granted 16,115 units of Ordinary Shares (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Tan Aik Na was granted 16,115 units of Ordinary Shares (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Takanashi Ken was granted 16,115 units of Ordinary Shares, increasing direct ownership by 0.28% to 5,721,175 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Corrigan Mark was granted 32,230 units of Ordinary Shares (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Verdine Gregory L. was granted 16,115 units of Ordinary Shares, increasing direct ownership by 54% to 46,115 units (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)
- Director Wagner Heidi L was granted 32,230 units of Ordinary Shares (SEC Form 4)4 - Wave Life Sciences Ltd. (0001631574) (Issuer)